Harpoon Therapeutics Inc Revenue per Employee (HARP), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Harpoon Therapeutics Inc   (NASDAQ: HARP)
 

Harpoon Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Harpoon Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 1,244,700, below the company average number of $892,279.
Within the Healthcare sector Employees of 74 other companies have achieved higher revenue per employee. While Harpoon Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 598 to 717. Harpoon Therapeutics Inc has 30 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HARP Revenue per Employee (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Revenue Change -67.33 % 143.54 % 45.33 % -5.46 % 203.68 %
Sales per Employee (TTM) $ 1,244,700 1,550,333 1,153,067 1,063,833 1,071,700
HARP's Total Ranking # 717 # 598 # 802 # 1012 # 882
Seq. Revenue Change -78 % 135.59 % 109.9 % -69.97 % 64 %

HARP Company Profile >> Back to HARP Efficiency Comparisons >> Compare HARP Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 8
Healthcare Sector # 75
Overall Market # 717

Revenue per Employee Statistics
High Average Low
$ 1,550,333 $ 892,279 $ 153,533
(Jun 30 2023)   (Sep 30 2019)



Financial Statements
Harpoon Therapeutics Inc 's Revenue MRQ $ 4 Millions Visit HARP's Income Statement
Harpoon Therapeutics Inc 's Revenues TTM $ 37 Millions Visit HARP's aggregate revenue growth
What are HARP's Sales? Visit HARP's Sales by Segment




Other Ratios
Harpoon Therapeutics Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
HARP's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for HARP's Competitors
Revenue per Employee for HARP's Suppliers
Revenue per Employee for HARP's Customers

You may also want to know
HARP's Sales Growth Rates HARP's Pe Price to earnings ratio HARP's Receivables Turnover Ratio HARP's Stock Quote
HARP's Net Income Growth Rates HARP's Ps Price to Sales ratio HARP's Sales per Employee HARP's Asset Turnover Ratio
HARP's Net Margin HARP's Pb Price to Book ratio HARP's Financial Strength Ratios HARP's Dividend Payout Ratio
Date modified: 2026-08-29T17:40:15+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2023Number of Employees Sep 30 2023
Amylyx Pharmaceuticals Inc   2,163,397.06 $ 294.222  Million 136 
Semler Scientific inc   2,158,774.19 $ 66.922  Million 31 
Prothena Corporation Public Limited Company  2,104,134.33 $ 140.977  Million 67 
Scilex Holding Company  2,097,500.00 $ 71.315  Million 34 
Intra cellular Therapies Inc   2,079,900.99 $ 420.140  Million 202 
Amgen Inc   2,064,076.92 $ 26,833.000  Million 13,000 
Opus Genetics Inc   2,043,142.86 $ 57.208  Million 28 
Prestige Consumer Healthcare Inc   1,975,589.47 $ 1,126.086  Million 570 
Therapeuticsmd Inc   1,952,000.00 $ 1.952  Million 1 
Moderna Inc   1,940,638.30 $ 9,121.000  Million 4,700 
Seres Therapeutics Inc   1,927,818.18 $ 127.236  Million 66 
Seagen Inc   1,916,959.17 $ 2,300.351  Million 1,200 
Catalyst Pharmaceuticals Inc   1,914,247.25 $ 348.393  Million 182 
Harmony Biosciences Holdings inc   1,848,539.25 $ 541.622  Million 293 
Halozyme Therapeutics Inc   1,845,650.12 $ 780.710  Million 423 
Marker Therapeutics inc   1,812,748.60 $ 9.064  Million 5 
Innoviva Inc   1,803,572.33 $ 286.768  Million 159 
Tvardi Therapeutics Inc   1,768,750.00 $ 21.225  Million 12 
Zymeworks Inc   1,748,405.30 $ 461.579  Million 264 
Palvella Therapeutics Inc   1,633,000.00 $ 47.357  Million 29 
Gilead Sciences Inc   1,611,235.29 $ 27,391.000  Million 17,000 
Elutia Inc   1,597,538.46 $ 41.536  Million 26 
United Therapeutics Corporation  1,574,500.00 $ 2,204.300  Million 1,400 
Exelixis Inc   1,547,055.80 $ 1,774.473  Million 1,147 
Ispecimen inc   1,473,518.71 $ 10.315  Million 7 
Paragon 28 inc   1,437,097.22 $ 206.942  Million 144 
Coherus Oncology inc   1,435,863.95 $ 211.072  Million 147 
Sangamo Therapeutics Inc   1,418,450.70 $ 201.420  Million 142 
Keenova Therapeutics Plc  1,416,312.50 $ 2,266.100  Million 1,600 
G1 Therapeutics Inc   1,416,145.45 $ 77.888  Million 55 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.